logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

David Lorente

Instituto Valenciano de Oncologia
H指数:36
被引数:5,200

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DEVELOPMENT AND VALIDATION OF A PROGNOSTIC MODEL TO GUIDE THE OPTIMAL TIMING OF DOCETAXEL AFTER AN ANDROGEN RECEPTOR PATHWAY INHIBITOR IN MCRPC

开发并验证一个预后模型，以指导在雄激素受体通路抑制剂后MCRPC患者中使用多西他赛的最佳时机

Journal of Urology
IF6.8
2026-05-010
PRE
Espana, Rodrigo Espana; Nogueira, Lola R.; Vico, Maria Ruiz; Villarubia, Jorge Esteban; Llacer, Casilda; Lozano, Rebeca; Romero-Laorden, Nuria; De-Velasco, Guillermo; Villatoro, Rosa; Garcia, Lucia; Saez, Felipe; Alvarez-Ballesteros, Pablo; Hernandez, David; Rodriguez-Antolin, Alfredo; Gonzalez-Billalabeitia, Enrique; Herrera-Imbroda, Bernardo; Castellano, Daniel; Lorente, David; Castro, Elena; Olmos, David
BRCA1/2 and homologous recombination repair alterations in high- and low-volume metastatic hormone-sensitive prostate cancer: prevalence and impact on outcomes

BRCA1/2和同源重组修复在高、低容量转移性激素敏感型前列腺癌中的改变: 患病率及其对预后的影响

Annals of Oncology
IF65.4
2025-06-020
OAAI
D. Olmos; D. Lorente; A. Jambrina; D. Tello-Velasco; M. Ovejero-Sánchez; I. Gonzalez-Ginel; N. Romero-Laorden; D. Nunes-Carneiro; M. Balongo; A.M. Gutierrez-Pecharromán; C. Llácer; J.D. Prieto; D. Pérez-Argüelles; F. Alberca del Arco; J. Miguel-Masiá; M. Ruiz-Vico; R. Santos; J. Esteban-Villarrubia; E. Gonzalez-Billalabeitia; A. Jürgens; C. Capone; M. Trevisan; S. Van Sanden; G. Stulnig; D. Hernández; P.P. López-Casas; A. Rodriguez-Antolin; D.E. Castellano; B. Herrera-Imbroda; E. Castro
Impact of FANCA, ATM, CDK12 alterations on survival in metastatic castration-resistant prostate cancer (mCRPC)

FANCA、ATM、CDK12改变对转移性去势抵抗性前列腺癌（mCRPC）生存的影响

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Lorente, D.; Herrera Imbroda, B.; Jambrina, A.; Tello, D.; Romero Laorden, N.; Lopez Casas, P.; Balongo, M.; Ovejero, M.; Almale, L.; Vidal Cassinello, N.; Mendez Vidal, M. J.; Capone, C.; Vanden Broecke, A. M.; Trevisan, M.; Van Sanden, S.; Juergens, A.; Gonzalez Billalabeitia, E.; Olmos, D.; Castro, E.
Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study

223镭治疗的转移性去势抵抗性前列腺癌患者的骨代谢生物标志物和生存率的前瞻性评估: PRORADIUM研究

EUROPEAN UROLOGY ONCOLOGY
IF9.3
2024-06-012
PRE
Romero-Laorden, Nuria; Lorente, David; de Velasco, Guillermo; Lozano, Rebeca; Herrera, Bernardo; Puente, Javier; Lopez, Pedro P.; Medina, Ana; Almagro, Elena; Gonzalez-Billalabeitia, Enrique; Villla-Guzman, Jose Carlos; Gonzalez-del-Alba, Aranzazu; Borrega, Pablo; Lainez, Nuria; Fernandez-Freire, Ana; Hernandez, Amaia; Rodriguez-Vida, Alejo; Chirivella, Isabel; Fernandez-Parra, Eva; Lopez-Campos, Fernando; Pacheco, Maria Isabel; Morales-Barrera, Rafael; Fernandez, Ovidio; Villatoro, Rosa; Luque, Raquel; Hernando, Susana; Castellano, Daniel C.; Castro, Elena; Olmos, David
Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes

伴或不伴同源重组修复基因体细胞或种系改变的转移性去势抵抗性前列腺癌患者的治疗模式和结果

ANNALS OF ONCOLOGY
IF65.4
2024-05-019
OA
Olmos, D.; Lorente, D.; Alameda, D.; Cattrini, C.; Romero-Laorden, N.; Lozano, R.; Lopez-Casas, P. P.; Jambrina, A.; Capone, C.; Vanden Broecke, A. M.; Trevisan, M.; Van Sanden, S.; Juergens, A.; Herrera-Imbroda, B.; Castro, E.
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers
EUROPEAN JOURNAL OF CANCER
IF7.1
2023-05-014
PRE
Lozano, Rebeca; Castro, Elena; -Campos, Fernando Lopez; Thorne, Heather; Ramirez-Backhaus, Miguel; Aragon, Isabel M.; Cendon-Florez, Ylenia; Gutierrez-Pecharroman, Ana; Salles, Daniela C.; Romero-Laorden, Nuria; Lorente, David; Gonzalez-Peramato, Pilar; Calatrava, Ana; Alonso, Concepcion; Anido, Urbano; Arevalo-Lobera, Sara; Balmana, Judith; Chirivella, Isabel; Juan-Fita, Maria Jose; Llort, Gemma; Cajal, Teresa Ramon Y.; Almagro, Elena; Alameda, Daniel; Lopez-Casas, Pedro P.; Herrera, Bernardo; Mateo, Joaquin; Pritchard, Colin C.; Antonarakis, Emmanuel S.; Lotan, Tamara L.; Rubio-Briones, Jose; Sandhu, Shahneen; Olmos, David
Adjuvant dabrafenib plus trametinib (DT) treatment completion in patients with resected melanoma in Spain: A retrospective observational study (GEM 1901-DESCRIBE-AD)
ANNALS OF ONCOLOGY
IF65.4
2021-09-011
OAAI
Manzano, J. L.; Martin-Liberal, J.; Fernandez-Morales, L. A.; Benitez, G.; Medina, J.; Quindos, M.; Garcia-Castano, A.; Fernandez, O.; Simo, R. Vilchez; Majem, M.; Hernandez, L. Bellido; de Miguel, P. Ayala; Campos, B.; Espinosa, E.; Cerrolaza, J. A. Macias; Gil-Arnaiz, I.; Lorente, D.; Martinez-Fernandez, A.; Martin-Sanchez, E.; Cerezuela-Fuentes, P.
Darolutamide maintenance in metastatic castration resistant prostate cancer (mCRPC) previously treated with novel hormonal agents (NHA) and non-progressive disease after subsequent treatment with a taxane: A randomized double-blind placebo-controlled phase II trial (SAKK 08/16)
ANNALS OF ONCOLOGY
IF65.4
2021-09-011
OAAI
Cathomas, R.; Procopio, G.; Hayoz, S.; Kremer, E. A.; Kienle, D.; Caffo, O.; Lorente, D.; Pedrazzini, A.; Roubaud, G.; Nenan, S.; Omlin, A. G.; Buttigliero, C.; Mestre, R. J. Pereira; Ribi, K.; Gillessen, S.
PRORADIUM: Prospective analysis of the impact of germline mutations in homologous recombination (HR) genes on the response to radium-223 for metastatic castration resistant prostate cancer (mCRPC)
ANNALS OF ONCOLOGY
IF65.4
2021-09-013
OAAI
Castro, E.; Lozano Mejorada, R.; Medina, A.; Giorgi, U.; Romero Laorden, N.; Conteduca, V.; De Velasco, G.; Alameda, D.; Sanz, A.; Puente, J.; Gonzalez del Alba, A.; Borrega, P.; Villa Guzman, J. C.; Fernandez-Parra, E. M.; Rodriguez-Vida, A.; Chirivella, I.; Vazquez, F.; Morales Barrera, R.; Lorente, D.; Olmos, D.
Role of serum biomarkers of bone metabolism in metastatic castration-resistance prostate cancer (mCRPC) patients (pts) treated with radium-223 (Ra223): PRORADIUM study final results
ANNALS OF ONCOLOGY
IF65.4
2021-09-010
OAAI
Romero Laorden, N.; Lorente, D.; Lozano Mejorada, R.; Sanchez-Soler, N.; De Velasco, G.; Puente, J.; Borrega, P.; Gonzalez-Billalabeitia, E.; Castillo-Morales, V.; Hernandez, A.; Fernandez-Freire, A.; Lopez Campos, F.; Villatoro, R.; Fernandez Calvo, O.; Anido, U.; Lainez, N.; Luque, R.; Ros Martinez, S.; Castro, E.; Olmos, D.
Differences in coping strategies used by colorectal vs. non-colorectal cancer patients: Data from the Neoetic-SEOM study
ANNALS OF ONCOLOGY
IF65.4
2021-07-010
OAAI
Pacheco-Barcia, V.; Hernandez Sangil, R.; Fernandez Montes, A.; Cruz Castellanos, P.; Castillo Trujillo, A.; Rogado, J.; Antonanzas, M.; Gil Raga, M.; Manzano, A.; Asensio, H.; Lorente, D.; Obispo, B.; Ostios, L.; Lopez de Ceballos, M.; Valero Arbizu, M.; Garcia Carrasco, M.; Maria Cano, J.; Piera, N.; Carmona-Bayonas, A.; Garcia, T.; Calderon, C.
Bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-ß and PD-L1: results from a phase I expansion cohort in patients with recurrent glioblastoma
NEURO-ONCOLOGY ADVANCES
IF4.1
2021-04-0921
OAAI
Khasraw, Mustafa; Weller, Michael; Lorente, David; Kolibaba, Kathryn; Lee, Chee Khoon; Gedye, Craig; de La Fuente, Macarena, I; Vicente, David; Reardon, David A.; Gan, Hui K.; Scott, Andrew M.; Dussault, Isabelle; Helwig, Christoph; Ojalvo, Laureen S.; Gourmelon, Carole; Groves, Morris

研究方向

暂未获取到该数据
J
Johann S. de Bono
H 指数:160论文数:2,491被引数:13.5万
D
Diletta Bianchini
H 指数:42论文数:200被引数:1.4万
D
David Olmos
H 指数:64论文数:471被引数:1.9万
J
Joaquı́n Mateo
H 指数:60论文数:453被引数:2.4万
G
Gerhardt Attard
H 指数:88论文数:573被引数:3.5万
R
Roberta Ferraldeschi
H 指数:39论文数:227被引数:1.2万
N
Nuria Romero-Laorden
H 指数:21论文数:147被引数:2,095
A
Aurelius Omlin
H 指数:47论文数:257被引数:1.1万
E
Elena Castro
H 指数:40论文数:248被引数:8,829
N
Nina Tunariu
H 指数:50论文数:440被引数:1.8万